Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine
Clinical trial NCT00856297 · COMPLETED
Trial details
- NCT number
- NCT00856297
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2012-11-01
- Enrollment
- 389
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.